CHEGG INC (CHGG) Fundamental Analysis & Valuation

NYSE:CHGG • US1630921096

Current stock price

0.73 USD
-0.02 (-2.81%)
At close:
0.7485 USD
+0.02 (+2.53%)
After Hours:

This CHGG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CHGG Profitability Analysis

1.1 Basic Checks

  • In the past year CHGG was profitable.
  • In the past year CHGG had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CHGG reported negative net income in multiple years.
  • Each year in the past 5 years CHGG had a positive operating cash flow.
CHGG Yearly Net Income VS EBIT VS OCF VS FCFCHGG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M -800M

1.2 Ratios

  • CHGG has a Return On Assets of -37.20%. This is in the lower half of the industry: CHGG underperforms 78.08% of its industry peers.
  • CHGG has a worse Return On Equity (-86.46%) than 71.23% of its industry peers.
Industry RankSector Rank
ROA -37.2%
ROE -86.46%
ROIC N/A
ROA(3y)-44.16%
ROA(5y)-24.34%
ROE(3y)-172.76%
ROE(5y)-98.91%
ROIC(3y)N/A
ROIC(5y)N/A
CHGG Yearly ROA, ROE, ROICCHGG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

  • Looking at the Gross Margin, with a value of 60.19%, CHGG is in the better half of the industry, outperforming 75.34% of the companies in the same industry.
  • CHGG's Gross Margin has declined in the last couple of years.
  • CHGG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.76%
GM growth 5Y-2.45%
CHGG Yearly Profit, Operating, Gross MarginsCHGG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

4

2. CHGG Health Analysis

2.1 Basic Checks

  • CHGG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CHGG has been increased compared to 1 year ago.
  • CHGG has less shares outstanding than it did 5 years ago.
  • CHGG has a better debt/assets ratio than last year.
CHGG Yearly Shares OutstandingCHGG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CHGG Yearly Total Debt VS Total AssetsCHGG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • CHGG has an Altman-Z score of -3.91. This is a bad value and indicates that CHGG is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -3.91, CHGG is not doing good in the industry: 73.97% of the companies in the same industry are doing better.
  • CHGG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.91
ROIC/WACCN/A
WACC3.75%
CHGG Yearly LT Debt VS Equity VS FCFCHGG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 0.86 indicates that CHGG may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.86, CHGG is doing worse than 68.49% of the companies in the same industry.
  • A Quick Ratio of 0.86 indicates that CHGG may have some problems paying its short term obligations.
  • CHGG's Quick ratio of 0.86 is on the low side compared to the rest of the industry. CHGG is outperformed by 61.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.86
CHGG Yearly Current Assets VS Current LiabilitesCHGG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

0

3. CHGG Growth Analysis

3.1 Past

  • CHGG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.05%.
  • CHGG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -53.01% yearly.
  • Looking at the last year, CHGG shows a very negative growth in Revenue. The Revenue has decreased by -38.97% in the last year.
  • The Revenue for CHGG have been decreasing by -10.17% on average. This is quite bad
EPS 1Y (TTM)-96.05%
EPS 3Y-71.46%
EPS 5Y-53.01%
EPS Q2Q%-105.88%
Revenue 1Y (TTM)-38.97%
Revenue growth 3Y-21.08%
Revenue growth 5Y-10.17%
Sales Q2Q%-49.36%

3.2 Future

  • CHGG is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -202.32% yearly.
  • Based on estimates for the next years, CHGG will show a very negative growth in Revenue. The Revenue will decrease by -26.42% on average per year.
EPS Next Y-797%
EPS Next 2Y-202.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-40.75%
Revenue Next 2Y-26.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHGG Yearly Revenue VS EstimatesCHGG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CHGG Yearly EPS VS EstimatesCHGG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1

1

4. CHGG Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 24.33 indicates a rather expensive valuation of CHGG.
  • Compared to the rest of the industry, the Price/Earnings ratio of CHGG is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 26.21. CHGG is around the same levels.
  • CHGG is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 24.33
Fwd PE N/A
CHGG Price Earnings VS Forward Price EarningsCHGG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CHGG is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.64
CHGG Per share dataCHGG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • A cheap valuation may be justified as CHGG's earnings are expected to decrease with -202.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-202.32%
EPS Next 3YN/A

0

5. CHGG Dividend Analysis

5.1 Amount

  • No dividends for CHGG!.
Industry RankSector Rank
Dividend Yield 0%

CHGG Fundamentals: All Metrics, Ratios and Statistics

CHEGG INC

NYSE:CHGG (4/7/2026, 7:00:00 PM)

After market: 0.7485 +0.02 (+2.53%)

0.73

-0.02 (-2.81%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)02-09
Earnings (Next)05-11
Inst Owners42.83%
Inst Owner Change0%
Ins Owners8.04%
Ins Owner Change29.15%
Market Cap81.61M
Revenue(TTM)376.91M
Net Income(TTM)-103.42M
Analysts42.86
Price TargetN/A
Short Float %6.67%
Short Ratio5.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)95.33%
Min EPS beat(2)90.66%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)-578.7%
Min EPS beat(4)-3041.18%
Max EPS beat(4)535.73%
EPS beat(8)6
Avg EPS beat(8)-287.18%
EPS beat(12)8
Avg EPS beat(12)-191.63%
EPS beat(16)12
Avg EPS beat(16)-138.11%
Revenue beat(2)2
Avg Revenue beat(2)0.17%
Min Revenue beat(2)0.02%
Max Revenue beat(2)0.33%
Revenue beat(4)3
Avg Revenue beat(4)1.03%
Min Revenue beat(4)-0.07%
Max Revenue beat(4)3.84%
Revenue beat(8)3
Avg Revenue beat(8)0.15%
Revenue beat(12)5
Avg Revenue beat(12)0.18%
Revenue beat(16)7
Avg Revenue beat(16)0.18%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-200%
EPS NY rev (1m)0%
EPS NY rev (3m)-2150%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-28.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-23.11%
Valuation
Industry RankSector Rank
PE 24.33
Fwd PE N/A
P/S 0.22
P/FCF N/A
P/OCF 5.27
P/B 0.68
P/tB 0.72
EV/EBITDA 0.64
EPS(TTM)0.03
EY4.11%
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)0.14
OCFY18.98%
SpS3.37
BVpS1.07
TBVpS1.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.85
Profitability
Industry RankSector Rank
ROA -37.2%
ROE -86.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.19%
FCFM N/A
ROA(3y)-44.16%
ROA(5y)-24.34%
ROE(3y)-172.76%
ROE(5y)-98.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.76%
GM growth 5Y-2.45%
F-Score6
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 35.76%
Cap/Sales 7.46%
Interest Coverage N/A
Cash Conversion 42.88%
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.86
Altman-Z -3.91
F-Score6
WACC3.75%
ROIC/WACCN/A
Cap/Depr(3y)65.15%
Cap/Depr(5y)90.8%
Cap/Sales(3y)10.4%
Cap/Sales(5y)11.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.05%
EPS 3Y-71.46%
EPS 5Y-53.01%
EPS Q2Q%-105.88%
EPS Next Y-797%
EPS Next 2Y-202.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.97%
Revenue growth 3Y-21.08%
Revenue growth 5Y-10.17%
Sales Q2Q%-49.36%
Revenue Next Year-40.75%
Revenue Next 2Y-26.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year471.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-125.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-87.63%
OCF growth 3Y-60.73%
OCF growth 5Y-42.02%

CHEGG INC / CHGG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CHEGG INC?

ChartMill assigns a fundamental rating of 2 / 10 to CHGG.


What is the valuation status for CHGG stock?

ChartMill assigns a valuation rating of 1 / 10 to CHEGG INC (CHGG). This can be considered as Overvalued.


Can you provide the profitability details for CHEGG INC?

CHEGG INC (CHGG) has a profitability rating of 2 / 10.


How financially healthy is CHEGG INC?

The financial health rating of CHEGG INC (CHGG) is 4 / 10.